Hypopituitarism after radiotherapy for extracranial head and neck cancers in pediatric patients

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 31, Issue 6, 2008, Pages 567-572

  Bhandare, Niranjan ^a   Kennedy, Laurence ^a   Malyapa, Robert S ^a   Morris, Christopher G ^a   Mendenhall, William M ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Head and neck cancer; Hypopituitarism; Outcomes; Pediatric; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG THERAPY; ENDOCRINE FUNCTION TEST; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOPITUITARISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MORBIDITY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; TREATMENT OUTCOME;

ADOLESCENT; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPITUITARISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROID GLAND;

EID: 58149250076     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318172dc9f     Document Type: Article

References (34)

1. Brauner R, Adan L, Souberbielle JC. Hypothalamic-pituitary function and growth in children with intracranial lesions. Childs Nerv Syst. 1999;15:662-669.
2. Darzy KH, Shalet SM. Radiation-induced growth hormone deficiency. Horm Res. 2003;59(suppl 1):1-11.
3. Bongers ME, Francken AB, Rouwe C, et al. Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation. Pediatr Blood Cancer. 2005;45:139-143.
4. Vance ML, Mauras N. Growth hormone therapy in adults and children. N Engl J Med. 1999;341:1206-1216.
5. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
6. Constine LS, Woolf PD, Cann D, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med. 1993;328:87-94.
7. Kirk JA, Raghupathy P, Stevens MM, et al. Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet. 1987;1:190-193.
8. Blatt J, Bereu BB, Gillin JC, et al. Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. J Pediatr. 1984;104:182-186.
9. Brennan BM, Rahim A, Mackie EM, et al. Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol (Oxf). 1998;48:777-783.
10. Sklar CA, Constine LS. Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys. 1995;31:1113-1121.
11. Kanumakala S, Warne GL, Zacharin MR. Evolving hypopituitarism following cranial irradiation. J Paediatr Child Health. 2003;39:232-235.
12. Birkebaek NH, Fisker S, Clausen N, et al. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 1998;30:351-356.
13. Drinnan CR, Miller JD, Guyda HJ, et al. Growth and development of long-term survivors of childhood acute lymphoblastic leukemia treated with and without prophylactic radiation of the central nervous system. Clin Invest Med. 1985;8:307-314.
14. Lando A, Holm K, Nysom K, et al. Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation. Clin Endocrinol (Oxf). 2001;55:21-25.
15. Rose SR, Danish RK, Kearney NS, et al. ACTH deficiency in childhood cancer survivors. Pediatr Blood Cancer. 2005;45:808-813.
16. Crowne EC, Wallace WH, Gibson S, et al. Adrenocorticotrophin and cortisol secretion in children after low dose cranial irradiation. Clin Endocrinol (Oxf). 1993;39:297-305.
17. Littley MD, Shalet SM, Beardwell CG, et al. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol (Oxf). 1989;31:363-373.
18. Schmiegelow M, Lassen S, Poulsen HS, et al. Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study. Clin Endocrinol (Oxf). 2000;53:191-197.
19. Rose SR, Schreiber RE, Kearney NS, et al. Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab. 2004;17:55-66.
20. Ogilvy-Stuart AL, Shalet SM. Effect of chemotherapy on growth. Acta Paediatr Suppl. 1995;411:52-56.
21. Ogilvy-Stuart AL, Shalet SM, Gattamaneni HR. Thyroid function after treatment of brain tumors in children. J Pediatr. 1991;119:733-737.
22. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, et al. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. J Clin Endocrinol Metab. 2003;88:3149-3154.
23. Chin D, Sklar C, Donahue B, et al. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy. Cancer. 1997;80:798-804.
24. Chrousos GP, Poplack D, Brown T, et al. Effects of cranial radiation on hypothalamic-adenohypophyseal function: abnormal growth hormone secretory dynamics. J Clin Endocrinol Metab. 1982;54:1135-1139.
25. Spoudeas HA, Hindmarsh PC, Matthews DR, et al. Evolution of growth hormone neurosecretory disturbance after cranial irradiation for childhood brain tumours: a prospective study. J Endocrinol. 1996;150:329-342.
26. Duffner PK, Cohen ME, Voorhess ML, et al. Long-term effects of cranial irradiation on endocrine function in children with brain tumors. A prospective study. Cancer. 1985;56:2189-2193.
27. Shalet SM, Beardwell CG, Morris-Jones PH, et al. Pituitary function after treatment of intracranial tumours in children. Lancet. 1975;2:104-107.
28. Chen MS, Lin FJ, Huang MJ, et al. Prospective hormone study of hypothalamic-pituitary function in patients with nasopharyngeal carcinoma after high dose irradiation. Jpn J Clin Oncol. 1989;19:265-270.
29. Shalet SM. Radiation and pituitary dysfunction. N Engl J Med. 1993; 328:131-133.
30. Brauner R, Czernichow P, Rappaport R. Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia. J Pediatr. 1986;108:332.
31. Albertsson-Wikland K, Lannering B, Marky I, et al. A longitudinal study on growth and spontaneous growth hormone (GH) secretion in children with irradiated brain tumors. Acta Paediatr Scand. 1987;76:966-973.
32. Atkinson SA, Fraher L, Gundberg CM, et al. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. J Pediatr. 1989;114:793-800.
33. Petraroli M, D'Alessio E, Ausili E, et al. Bone mineral density in survivors of childhood brain tumours. Childs Nerv Syst. 2007;23:59-65.
34. Oberfield SE, Soranno D, Nirenberg A, et al. Age at onset of puberty following high-dose central nervous system radiation therapy. Arch Pediatr Adolesc Med. 1996;150:589-592.